🔹Suramin for Autism Update: 2023 and Beyond

Brought to you by the BRAIN FoundationIn partnership with PaxMedica About the event An exclusive interview with Howard Weisman, CEO of PaxMedica, on the latest developments and plans for FDA approval for suramin, a potential breakthrough treatment for autism.

https://brainfoundation.org/suramin-for-autism-update-2023/

🔸BRAIN Foundation Presents: Suramin for Autism in 2023 and Beyond, with Howard Weisman CEO, PaxMedica
An exclusive interview on the latest developments and plans for FDA approval for suramin, a potential breakthrough treatment for autism.
Howard Weisman CEO, PaxMedica shares with us a detailed update on the development of suramin as an evidence-based therapeutic for autism, clinical trial results, go-forward plans to seek FDA approval, international availability, and the possibility of expanded access for compassionate use for autism.

https://www.youtube.com/watch?v=8424DnJcRF4